These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3549304)

  • 1. The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes.
    Russell DG
    Eur J Biochem; 1987 Apr; 164(1):213-21. PubMed ID: 3549304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement receptor type 3 (CR3) binds to an Arg-Gly-Asp-containing region of the major surface glycoprotein, gp63, of Leishmania promastigotes.
    Russell DG; Wright SD
    J Exp Med; 1988 Jul; 168(1):279-92. PubMed ID: 3294332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages.
    Russell DG; Wilhelm H
    J Immunol; 1986 Apr; 136(7):2613-20. PubMed ID: 3950420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan.
    Puentes SM; Sacks DL; da Silva RP; Joiner KA
    J Exp Med; 1988 Mar; 167(3):887-902. PubMed ID: 3280727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid protease activity of a major surface membrane glycoprotein (gp63) from Leishmania mexicana promastigotes.
    Chaudhuri G; Chang KP
    Mol Biochem Parasitol; 1988 Jan; 27(1):43-52. PubMed ID: 3278222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies raised against synthetic peptides from the Arg-Gly-Asp-containing region of the Leishmania surface protein gp63 cross-react with human C3 and interfere with gp63-mediated binding to macrophages.
    Russell DG; Talamas-Rohana P; Zelechowski J
    Infect Immun; 1989 Feb; 57(2):630-2. PubMed ID: 2912899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy.
    Wozencraft AO; Sayers G; Blackwell JM
    J Exp Med; 1986 Oct; 164(4):1332-7. PubMed ID: 3531384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Leishmania gp63 with cellular receptors for fibronectin.
    Brittingham A; Chen G; McGwire BS; Chang KP; Mosser DM
    Infect Immun; 1999 Sep; 67(9):4477-84. PubMed ID: 10456889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gp72, the 72 kilodalton glycoprotein, is the membrane acceptor site for C3 on Trypanosoma cruzi epimastigotes.
    Joiner K; Hieny S; Kirchhoff LV; Sher A
    J Exp Med; 1985 May; 161(5):1196-212. PubMed ID: 3886827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The major surface glycoprotein (GP63) is present in both life stages of Leishmania.
    Frommel TO; Button LL; Fujikura Y; McMaster WR
    Mol Biochem Parasitol; 1990 Jan; 38(1):25-32. PubMed ID: 2181303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania species: mechanisms of complement activation by five strains of promastigotes.
    Mosser DM; Burke SK; Coutavas EE; Wedgwood JF; Edelson PJ
    Exp Parasitol; 1986 Dec; 62(3):394-404. PubMed ID: 3780933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the major surface glycoprotein of Leishmania donovani chagasi in virulent and attenuated promastigotes.
    Wilson ME; Hardin KK; Donelson JE
    J Immunol; 1989 Jul; 143(2):678-84. PubMed ID: 2738406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis.
    Brittingham A; Morrison CJ; McMaster WR; McGwire BS; Chang KP; Mosser DM
    J Immunol; 1995 Sep; 155(6):3102-11. PubMed ID: 7673725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM; Edelson PJ
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages.
    Wozencraft AO; Blackwell JM
    Immunology; 1987 Apr; 60(4):559-63. PubMed ID: 2953670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania amazonensis promastigotes evade complement killing by interfering with the late steps of the cascade.
    Nunes AC; Almeida-Campos FR; Horta MF; Ramalho-Pinto FJ
    Parasitology; 1997 Dec; 115 ( Pt 6)():601-9. PubMed ID: 9488871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heterogeneity of Leishmania cell-surface antigens.
    Hernández AG; Payares G; Misle A; Dagger F
    Parasitol Res; 1989; 75(8):583-8. PubMed ID: 2771925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism.
    Ambrosio AR; De Messias-Reason IJ
    Parasite Immunol; 2005 Sep; 27(9):333-40. PubMed ID: 16149991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody.
    Barbiéri CL; Giorgio S; Merjan AJ; Figueiredo EN
    Infect Immun; 1993 May; 61(5):2131-7. PubMed ID: 7683002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The major Leishmania donovani chagasi surface glycoprotein in tunicamycin-resistant promastigotes.
    Wilson ME; Hardin KK
    J Immunol; 1990 Jun; 144(12):4825-34. PubMed ID: 2191040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.